Trial Profile
Evalutation of maraviroc therapy in PI-treated HIV+ patients at intermediate-low risk for cardiovascular diseases: a phase IV, randomized, open study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections; Hypertriglyceridaemia
- Focus Pharmacodynamics
- 08 Dec 2015 New trial record